Close

Summit Therapeutics (SMMT) Receives FDA Fast Track Status for DMD Treatment

Go back to Summit Therapeutics (SMMT) Receives FDA Fast Track Status for DMD Treatment
Stratcomm Media, Ltd. (NASDAQ: SMMT) Delayed: 3.48 -0.11 (3.06%)
Previous Close $3.59    52 Week High $19.75 
Open $3.52    52 Week Low $4.26 
Day High $3.58    P/E N/A 
Day Low $3.47    EPS $0.00 
Volume 57,369